Baillieu`s has increased target for PNV to .70c with a high risk buy recommendation. The report has 2020 fy sales at
$63m, reported profit at $30.9m and PE of 11.2 based on sp of 52c. These figures are based on existing products in the market so plenty of blue sky for change brought about by pipeline products hernia and breast etc etc.
blue skies
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.56 |
Change
-0.050(1.92%) |
Mkt cap ! $1.768B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.65 | $2.55 | $4.577M | 1.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21966 | $2.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.57 | 1899 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |